Unique ID issued by UMIN | UMIN000010113 |
---|---|
Receipt number | R000011776 |
Scientific Title | A phase II clinical trial of neoadjyvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer |
Date of disclosure of the study information | 2013/03/01 |
Last modified on | 2013/02/25 19:33:48 |
A phase II clinical trial of neoadjyvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer
Neoadjuvant chemoradiation therapy for locally advanced pancreatic cancer
A phase II clinical trial of neoadjyvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer
Neoadjuvant chemoradiation therapy for locally advanced pancreatic cancer
Japan |
borderline resectable pancreatic cancer
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of neoadjuvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer.
Safety,Efficacy
Exploratory
Phase I,II
Histological curative resection rate
(R0 Ratio)
pathological responce rate,
progression free survival, over all survival, incident of adverse event, mortality
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Maneuver |
To investigate the frequency of histological curative resection following chemoradiation using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer
20 | years-old | <= |
80 | years-old | > |
Male and Female
1.Patients with Histo-cytologically confirmed pancreatic cancer
2.Patients with radiologically defined patentially borderline resectable pancreatic cancer
3.Patients with Performance status of 0/1
4.Patients who have not undergone chemo and/or radiotherapyPatients with no metastatic disease confirmed by staging laparoscopy
5.Patiants who can oral intake
6.Patients with normal ECG findings
7.Patients with sustained organ function
8.Patients who received informed consent
1) Patients with lung fibrosis or interstitional pneumonia
2) Patients who can not underwent radiation therapy because of past radiation therapy
3) Severe co-morbid diseases
4) Intractable pleural and pericardical effusion, or ascites
5) Patients with other active cancers
6)Pregnancy or insufficient contraception
7) severe mental illness
8) Patients seems inadequate for this study by investigator(s)
37
1st name | |
Middle name | |
Last name | Kyoichi Takaori |
Graduate School of Medicine and Faculty of Medicine KyotoUniversity
Hepato-pancreato-biliary Surgery and Transplantation
54 Kawaharacho, Shogoin, Sakyo-ku Kyoto,
075-751-4323
1st name | |
Middle name | |
Last name | Masaki Mizumoto |
Graduate School of Medicine and Faculty of Medicine KyotoUniversity
Hepato-pancreato-biliary Surgery and Transplantation
54 Kawaharacho, Shogoin, Sakyo-ku Kyoto,
075-751-4323
mizumoto@kuhp.kyoto-u.ac.jp
Hepato-pamcreato-biliary Surgery and Transplantation,
Graduate School of Medicine and Faculty of Medicine KyotoUniversity
Hepato-pamcreato-biliary Surgery and Transplantation,
Graduate School of Medicine and Faculty of Medicine KyotoUniversity
Self funding
NO
京都大学医学部付属病院
2013 | Year | 03 | Month | 01 | Day |
Unpublished
Preinitiation
2013 | Year | 01 | Month | 24 | Day |
2013 | Year | 04 | Month | 01 | Day |
2013 | Year | 02 | Month | 25 | Day |
2013 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011776